A Randomized Controlled Trial of a 3-year Home Exercise Program in Cystic Fibrosis
Overview
Affiliations
Objectives: To evaluate the effects of a 3-year home exercise program on pulmonary function and exercise tolerance in mildly to moderately impaired patients with cystic fibrosis (CF) and to assess whether regular aerobic exercise is a realistic treatment option.
Study Design: Seventy-two patients with CF (7-19 years) were randomly assigned to an exercise group (a minimum of 20 minutes of aerobic exercise, at a heart rate of approximately 150 beats/min, 3 times weekly) or a control group (usual physical activity participation). Pulmonary function, exercise tolerance, clinical status, hospitalizations, and compliance with therapy were monitored during scheduled visits to the hospital's CF clinic.
Results: Sixty-five patients were included in the analyses. The control group demonstrated a greater annual decline in percent of predicted forced vital capacity compared with the exercise group (mean slope +/- SD, -2.42 +/- 4.15 vs -0.25 +/- 2.81; P =.02), with a similar trend for forced expiratory volume in 1 second (-3.47 +/- 4.93 vs -1.46 +/- 3. 55; P =.07). Patients remained compliant with the exercise program over the study period. An improved sense of well-being was reported with exercise.
Conclusions: Pulmonary function declined more slowly in the exercise group than in the control group, suggesting a benefit for patients with CF participating in regular aerobic exercise. Consistent compliance with the home exercise program and a self-reported positive attitude toward exercise provide further evidence of the feasibility and value of including an aerobic exercise program in the conventional treatment regimen of patients with CF.
Impact of CFTR modulators on exercise capacity in adolescents with cystic fibrosis.
Ahmed M, Dayman N, Blyth N, Madge J, Gaillard E ERJ Open Res. 2024; 10(1).
PMID: 38375430 PMC: 10875456. DOI: 10.1183/23120541.00687-2023.
Physical Activity and Quality of Life among Patients with Cystic Fibrosis.
Giannakoulakos S, Gioulvanidou M, Kouidi E, Peftoulidou P, Kyrvasili S, Savvidou P Children (Basel). 2022; 9(11).
PMID: 36360393 PMC: 9688592. DOI: 10.3390/children9111665.
Dillenhoefer S, Stehling F, Welsner M, Schlegtendal A, Sutharsan S, Olivier M Int J Environ Res Public Health. 2022; 19(20).
PMID: 36293733 PMC: 9603748. DOI: 10.3390/ijerph192013150.
Physical activity and exercise training in cystic fibrosis.
Radtke T, Smith S, Nevitt S, Hebestreit H, Kriemler S Cochrane Database Syst Rev. 2022; 8:CD002768.
PMID: 35943025 PMC: 9361297. DOI: 10.1002/14651858.CD002768.pub5.
Adair D, Hider A, Filbrun A, Tapley C, Bouma S, Iwanicki C Front Pediatr. 2022; 9:734292.
PMID: 35096701 PMC: 8793844. DOI: 10.3389/fped.2021.734292.